United States · Bill · HR
H.R. 4829 (109th)
Reducing Fraudulent and Imitation Drugs Act of 2006
Introduced
1 March 2006
Last action
17 March 2006 · Referred
Status
Referred to the Subcommittee on Health.
Sponsors
Rep. Burton, Dan [R-IN-5], Rep. Gutknecht, Gil [R-MN-1], Sen. Sanders, Bernard [I-VT], Rep. Emanuel, Rahm [D-IL-5], Rep. Herseth Sandlin, Stephanie [D-SD-At Large], Rep. Northup, Anne M. [R-KY-3], Rep. Jones, Walter B., Jr. [R-NC-3], Rep. DeFazio, Peter A. [D-OR-4], Rep. Souder, Mark E. [R-IN-3], Rep. DeLauro, Rosa L. [D-CT-3], Rep. Wamp, Zach [R-TN-3], Rep. English, Phil [R-PA-3], Rep. Shays, Christopher [R-CT-4]
Subjects
Healthcare
Source updated
15 August 2025
Summary
Reducing Fraudulent and Imitation Drugs Act of 2006 - Directs the Secretary of Health and Human Services to require prescription drug packaging to incorporate: (1) radio frequency tagging technology or similar trace and track technologies; (2) tamper-indicating technologies; and (3) blister security packaging when possible. Directs the Secretary to: (1) require that such technologies be used exclusively to authenticate the pedigree of prescription drugs; and (2) prohibit such technologies from containing or transmitting any identifying information of a health care practitioner or consumer, or any advertisement or information about indications or off-label uses. Requires the Secretary to encourage prescription drug manufacturers and distributors to incorporate: (1) overt optically variable counterfeit-resistant technologies into packaging; and (2) required prescription drug packaging technologies into multiple elements of the physical packaging of the drugs. Requires prescription drug shipments to include a label on the shipping container that incorporates packaging technologies. Deems a prescription drug to be misbranded if the packaging or labeling of the drug is in violation of a requirement or prohibition of this Act. Requires the Secretary to publish the National Specified List of Susceptible Prescription Drugs, consisting of not less than 30 of the most frequently counterfeited prescription drugs in the United States.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
1 March 2006
Introduced
Referred to the House Committee on Energy and Commerce.
Source: IntroReferral
1 March 2006
Introduced
Introduced in House
Source: IntroReferral
1 March 2006
Introduced
Introduced in House
Source: IntroReferral
17 March 2006
Referred
Referred to the Subcommittee on Health.
Source: Committee
Votes
No vote records are attached yet.
Versions
- Introduced in House · 1 March 2006 · Download file
Documents
3 official files
Introduced in House (text)
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House (text)
Introduced in House · EN · 1 March 2006
Introduced in House (PDF)
Introduced in House · EN · 1 March 2006
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
summary · EN · 1 March 2006
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Rep. Burton, Dan [R-IN-5] · R · Sponsor
- Rep. Gutknecht, Gil [R-MN-1] · R · Sponsor
- Sen. Sanders, Bernard [I-VT] · I · Sponsor
- Rep. Emanuel, Rahm [D-IL-5] · D · Sponsor
- Rep. Herseth Sandlin, Stephanie [D-SD-At Large] · D · Sponsor
- Rep. Northup, Anne M. [R-KY-3] · R · Sponsor
- Rep. Jones, Walter B., Jr. [R-NC-3] · R · Sponsor
- Rep. DeFazio, Peter A. [D-OR-4] · D · Sponsor
- Rep. Souder, Mark E. [R-IN-3] · R · Sponsor
- Rep. DeLauro, Rosa L. [D-CT-3] · D · Cosponsor
- Rep. Wamp, Zach [R-TN-3] · R · Cosponsor
- Rep. English, Phil [R-PA-3] · R · Cosponsor
- Rep. Shays, Christopher [R-CT-4] · R · Cosponsor
- · hsif00 · Standing
Related records
- related to ← Reducing Fraudulent and Imitation Drugs Act of 2006
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/109th-congress/house-bill/4829
- Open data entity: https://api.congress.gov/v3/bill/109/hr/4829
- us · 109-hr-4829 · source updated 15 August 2025